American International Group, Inc. Cytosorbents Corp Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.22 $36,032 - $65,923	-20,473 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.88 - $4.23 $4,150 - $6,095	-1,441 Reduced 6.58%	20,473 $65,000
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $2,652 - $5,312	-655 Reduced 2.9%	21,914 $92,000
Q3 2021 Nov 12, 2021	SELL	$7.0 - $9.71 $3,759 - $5,214	-537 Reduced 2.32%	22,569 $183,000
Q2 2021 Aug 13, 2021	SELL	$7.55 - $9.42 $6,311 - $7,875	-836 Reduced 3.49%	23,106 $174,000
Q1 2021 May 07, 2021	BUY	$8.23 - $11.48 $526 - $734	64 Added 0.27%	23,942 $208,000
Q4 2020 Feb 12, 2021	SELL	$7.65 - $8.98 $5,247 - $6,160	-686 Reduced 2.79%	23,878 $190,000
Q3 2020 Nov 04, 2020	BUY	$7.37 - $11.54 $25,603 - $40,089	3,474 Added 16.47%	24,564 $196,000
Q2 2020 Aug 12, 2020	BUY	$6.28 - $10.59 $18,620 - $31,399	2,965 Added 16.36%	21,090 $209,000
Q1 2020 May 04, 2020	SELL	$3.77 - $7.73 $3,943 - $8,085	-1,046 Reduced 5.46%	18,125 $140,000
Q4 2019 Feb 05, 2020	SELL	$3.61 - $5.22 $584 - $845	-162 Reduced 0.84%	19,171 $74,000
Q3 2019 Nov 08, 2019	SELL	$4.33 - $7.63 $584 - $1,030	-135 Reduced 0.69%	19,333 $97,000
Q2 2019 Aug 13, 2019	BUY	$5.92 - $7.78 $2,971 - $3,905	502 Added 2.65%	19,468 $129,000
Q1 2019 May 06, 2019	SELL	$6.82 - $8.56 $4,194 - $5,264	-615 Reduced 3.14%	18,966 $144,000
Q4 2018 Feb 13, 2019	SELL	$7.05 - $12.64 $1,057 - $1,896	-150 Reduced 0.76%	19,581 $158,000
Q3 2018 Nov 09, 2018	BUY	$10.95 - $14.8 $13,512 - $18,263	1,234 Added 6.67%	19,731 $255,000
Q2 2018 Aug 08, 2018	BUY	$6.9 - $12.35 $127,629 - $228,437	18,497 New	18,497 $211,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $65.4M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.